You are here: Industry Insights > acquire

News List

Shiseido acquires leading skincare brand biospectrumasia
October 08, 2019
Drunk Elephant was founded in 2012 by Tiffany Masterson as a solutions-oriented, cross-generational brand for all skin types, and has since experienced exponential growth across a full range of consumer demographics, including Gen Z and Millennials.
Biotech Conagen Acquires Production Platform of Therapeutic Proteins americanpharmaceuticalreview
August 23, 2019
Conagen, a vertically integrated synthetic biology company located in Boston's biotech corridor, has acquired a fermentation-based technology for the production of therapeutically useful glycoproteins.
GeneCentric Therapeutics Acquires Select ImmunoGenomics americanpharmaceuticalreview
August 20, 2019
GeneCentric Therapeutics has acquired Select ImmunoGenomics, a Chapel Hill, NC-based provider of advanced immunogenomic, data analysis and biomarker development services to support the development of immuno-oncology drugs.
Bayer agrees to acquire biotech BlueRock for $1bn pharmaceutical-technology
August 09, 2019
German multinational pharmaceutical company Bayer has signed an agreement to acquire US-based biotechnology company BlueRock Therapeutics.
ACG Engineering acquires Germany’s Xertecs pharmaceutical-technology
August 05, 2019
ACG Group unit ACG Engineering (ACGE) has purchased 100% shares of German pharmaceutical processing equipment provider Xertecs for an undisclosed amount.
ACG Acquires Pharma Processing Equipment Provider Xertecs contractpharma
August 05, 2019
German firm develops and implements processes, products and services for pharma companies around the world.
Yellow Wood Partners to acquire Dr. Scholl’s from Bayer biospectrumasia
July 23, 2019
With the acquisition of Dr. Scholl’s™, Yellow Wood Partners will create a stand-alone company in which it plans to invest in all aspects of the business to drive the growth and profitability of the brand
Altimmune Signs Agreement to Acquire Spitfire Pharma contractpharma
July 10, 2019
Receives rights to NASH drug candidate, SP-1373.
FSD Pharma closes deal and acquires Prismic Pharmaceuticals biospectrumasia
July 08, 2019
The FSD Shares issued to the former Prismic shareholders were deposited into escrow at the closing of the Transaction, and are subject to an 18-month staggered release.
AbbVie is to acquire Allergan in a ‘transformative transaction’ europeanpharmaceuticalreview
June 28, 2019
AbbVie Inc. and Allergan plc have entered into a definitive transaction agreement under which AbbVie will acquire Allergan.

Previous page 1 2 3 4 5 Next page